NCT05106686View on ClinicalTrials.gov

Effect of Aureobasidium Pullulans Produced β-glucan on Musculoskeletal Biomarkers in Adults With Relative Sarcopenia

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

May 31, 2022

Conditions
Sarcopenia
Interventions
DIETARY_SUPPLEMENT

Aureobasidium pullulans produced β-glucan group

Aureobasidium pullulans produced β-glucan 1,000 mg/day for 12 weeks

DIETARY_SUPPLEMENT

placebo group

Placebo 300 mg/day for 12 weeks

Trial Locations (1)

50612

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors
lead

Pusan National University Yangsan Hospital

OTHER

NCT05106686 - Effect of Aureobasidium Pullulans Produced β-glucan on Musculoskeletal Biomarkers in Adults With Relative Sarcopenia | Biotech Hunter | Biotech Hunter